Discovery, development and effectiveness of coagulation-inhibiting drugs for stroke therapy

Author： Killer Monika Trinka Eugen Kraus Jöörg Broussalis Erasmia

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.6, Iss.4, 2011-04, pp. : 353-369

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stroke therapy in traditional Chinese medicine (TCM): prospects for drug discovery and development

By Gong X. Sucher N.J.

Trends in Pharmacological Sciences, Vol. 20, Iss. 5, 1999-05 ,pp. : 191-196

Elsevier

Access to resources Recommend Favorite

Acute Stroke Therapy: Combination Drugs and Multifunctional Neuroprotectants

Current Neuropharmacology, Vol. 2, Iss. 3, 2004-07 ,pp. : 277-294

Bentham Science Publishers

Access to resources Recommend Favorite

Development of thrombolytic therapy for stroke: a perspective

By Lapchak Paul A

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1623-1632

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in the Discovery and Development of Direct Coagulation Factor Xa Inhibitors

Current Pharmaceutical Design, Vol. 9, Iss. 28, 2003-11 ,pp. : 2337-2347

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and Development of the Epothilones: A Novel Class of Antineoplastic Drugs

By Reichenbach Hans Höfle Gerhard

Drugs in R&D, Vol. 9, Iss. 1, 2008-01 ,pp. : 1-10

Adis International

Access to resources Recommend Favorite